Radius health announces second quarter 2020 operating results

Radius health announces second quarter 2020 operating results.q2 adjusted non-gaap loss per share $0.67 excluding items.q2 earnings per share estimate $-0.74 -- refinitiv ibes data.q2 loss per share $0.95.phase 3 trials wearable and emerald remain on track.completion of enrollment in atom phase 3 expected this week.q2 2020 u.s. net sales of tymlos were $50.1 million, a 22% increase.q2 revenue view $47.4 million -- refinitiv ibes data.
RDUS Ratings Summary
RDUS Quant Ranking